Volume 27, Number 1—January 2021
Research
Precise Species Identification by Whole-Genome Sequencing of Enterobacter Bloodstream Infection, China
Table 4
Antimicrobial resistance rates in E. xiangfangensis plus taxon 1 and other Enterobacter spp. in genomic study of Enterobacter bloodstream infection, China*
| Antimicrobial agent | No. (%) |
χ2 | p value | Power† | |
|---|---|---|---|---|---|
| E. xiangfangensis + taxon 1, n = 29 | Other species, n = 19 | ||||
| Amikacin | 2 (6.9) | 0 | – | 0.512 | ND |
| Gentamicin | 9 (31.0) | 1 (5.3) | 3.192 | 0.074 | 0.600 |
| Tobramycin | 13 (44.8) | 1 (5.3) | 8.698 | 0.003 | – |
| Aztreonam | 14 (48.3) | 2 (10.5) | 7.361 | 0.007 | 0.829 |
| Cefepime | 12 (41.4) | 2 (10.5) | 5.289 | 0.021 | – |
| Ceftriaxone | 17 (58.6) | 3 (15.8) | 8.664 | 0.003 | – |
| Imipenem | 8 (27.6) | 2 (10.5) | 1.123 | 0.289 | 0.258 |
| Piperacillin/tazobactam | 12 (41.4) | 2 (10.5) | 5.289 | 0.021 | – |
| Ciprofloxacin | 11 (37.9) | 0 | 7.326 | 0.007 | ND |
| Levofloxacin | 11 (37.9) | 0 | 7.326 | 0.007 | ND |
| Colistin | 10 (34.5) | 6 (31.6) | 0.044 | 0.835 | 0.052 |
| Tigecycline | 5 (17.2) | 0 | 2.043 | 0.153 | ND |
| Trimethoprim/sulfamethoxazole | 12 (41.4) | 0 | 8.392 | 0.004 | ND |
*Bold indicates significance. ND, not determined; –, not calculated. †Statistical power was calculated for parameters without statistical significance (p>0.05) but could not be calculated for any parameters being 0.
1These authors contributed equally to this article.
Page created: November 24, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.